Drug Enforcement Administration May 2018 – Federal Register Recent Federal Regulation Documents

Schedules of Controlled Substances: Temporary Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA Into Schedule I
Document Number: 2018-11531
Type: Proposed Rule
Date: 2018-05-30
Agency: Drug Enforcement Administration, Department of Justice
The Acting Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule the synthetic cannabinoids, Naphthalen-1-yl 1-(5- fluoropentyl)-1H-indole-3-carboxylate (trivial name: NM2201; CBL2201); N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-in dazole-3- carboxamide (trivial name: 5F-AB-PINACA); 1-(4-cyanobutyl)-N-(2- phenylpropan-2-yl)-1H-indazole-3-carboxamide (trivial name: 4-CN-CUMYL- BUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78); methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3- methylbutanoate (trivial names: MMB-CHMICA, AMB-CHMICA); and 1-(5- fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridi ne-3- carboxamide (trivial name: 5F-CUMYL-P7AICA), in schedule I. This action is based on a finding by the Acting Administrator that the placement of these synthetic cannabinoids in schedule I of the Controlled Substances Act (CSA) is necessary to avoid an imminent hazard to the public safety. When it is issued, the temporary scheduling order will impose regulatory requirements under the CSA on the manufacture, distribution, reverse distribution, possession, importation, exportation, research, and conduct of instructional activities, and chemical analysis of these synthetic cannabinoids, as well as administrative, civil, and criminal remedies with respect to persons who fail to comply with such requirements or otherwise violate the CSA with respect to these substances.
Jopindar P. Harika, M.D.; Order
Document Number: 2018-11433
Type: Notice
Date: 2018-05-29
Agency: Drug Enforcement Administration, Department of Justice
Health Fit Pharmacy; Decision and Order
Document Number: 2018-11268
Type: Notice
Date: 2018-05-25
Agency: Drug Enforcement Administration, Department of Justice
Donald Kenneth Shreves, D.V.M.; Dismissal of Proceeding
Document Number: 2018-10305
Type: Notice
Date: 2018-05-15
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2018-10304
Type: Notice
Date: 2018-05-15
Agency: Drug Enforcement Administration, Department of Justice
Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as bulk manufacturers of various classes of schedule I and II controlled substances.
Bulk Manufacturer of Controlled Substances Application: Patheon API Manufacturing, Inc.
Document Number: 2018-10303
Type: Notice
Date: 2018-05-15
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Rhodes Technologies
Document Number: 2018-10302
Type: Notice
Date: 2018-05-15
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Mylan Pharmaceuticals, Inc.
Document Number: 2018-10301
Type: Notice
Date: 2018-05-15
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Xcelience
Document Number: 2018-10300
Type: Notice
Date: 2018-05-15
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Extension of Temporary Placement of beta-Hydroxythiofentanyl in Schedule I of the Controlled Substances Act
Document Number: 2018-10009
Type: Rule
Date: 2018-05-10
Agency: Drug Enforcement Administration, Department of Justice
The Acting Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to extend the temporary schedule I status of beta-hydroxythiofentanyl (N-[1-[2- hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropio namide) also known as N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N- phenylpropanamide including its isomers, esters, ethers, salts and salts of isomers, esters and ethers. The schedule I status of beta- hydroxythiofentanyl currently is in effect through May 12, 2018. This temporary order will extend the temporary scheduling of beta- hydroxythiofentanyl for one year, or until the permanent scheduling action for this substance is completed, whichever occurs first.
Schedules of Controlled Substances: Placement of beta-Hydroxythiofentanyl Into Schedule I
Document Number: 2018-10008
Type: Proposed Rule
Date: 2018-05-10
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration proposes placing beta- hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin- 4-yl]-N-phenylpropionamide) also known as N-[1-[2-hydroxy-2-(2- thienyl)ethyl]4-piperidinyl]N-phenyl-propanamide including its isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle beta-hydroxythiofentanyl.
William R. Montiel, M.D.; Decision and Order
Document Number: 2018-09738
Type: Notice
Date: 2018-05-08
Agency: Drug Enforcement Administration, Department of Justice
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.